Skip to main content

Anna Meseguer Navarro

Institutions of which they are part

Head of group
Kidney Physiopathology
Vall Hebron Institut de Recerca

Anna Meseguer Navarro

Institutions of which they are part

Head of group
Kidney Physiopathology
Vall Hebron Institut de Recerca

Projects

Patologia Cel·lular

IP: Anna Meseguer Navarro
Collaborators: Joan López Hellin, Ramón Vilalta Casas, Alvaro Domingo Madrid Aris, Francesc Moreso Mateos, Enric Trilla Herrera, Daniel Serón Micas, Luis Enrique Lara Moctezuma, Patologia Cel·lular, Concepció Jacobs Cachá, Carles Xavier Raventós Busquets
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2009 SGR 75
Duration: 01/01/2010 - 30/04/2014

Implicación de la ciclofilina B (CYBP) y de las proteínas que con ella interaccionan, en el daño renal agudo

IP: Anna Meseguer Navarro
Collaborators: Joan López Hellin, Implicación de la ciclofilina B (CYBP) y de las proteínas que con ella interaccionan, en el daño renal agudo
Funding agency: Fundación Renal Iñigo Alvarez de Toledo
Funding: 18000
Reference: FRIAT_01_2007
Duration: 01/01/2008 - 31/12/2009

Mecanismos moleculares implicados en la nefrotoxicidad producida por Ciclosporina A (CsA) y FK506 en el túbulo proximal renal.

IP: Anna Meseguer Navarro
Collaborators: Joan López Hellin
Funding agency: Instituto de Salud Carlos III
Funding: 154675
Reference: PI020829
Duration: 06/11/2002 - 06/11/2005

Implicacions del receptor del virus de l'hepatitis A humà (hHAVcr-1) en el desenvolupament i la progressió del carcinoma renal. Valor com a marcador diagnòstic i pronòstic en els carcinomes de bufeta i renals

IP: Anna Meseguer Navarro
Collaborators: Santiago Ramon y Cajal Agüeras, Joan Morote Robles, Enric Trilla Herrera, Implicacions del receptor del virus de l'hepatitis A humà (hHAVcr-1) en el desenvolupament i la progressió del carcinoma renal.
Funding agency: Fundació La Marató de TV3
Funding: 204625
Reference: TV3/052410
Duration: 01/01/2006 - 30/04/2010

Related news

The work identifies variants in genes such as NFU1 that, combined with the disease-causing mutation, can accelerate kidney deterioration.

The communication is part of a study aimed at identifying the mechanisms of progression of Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis, a rare disease that affects the kidneys.

"Patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis present miRNA profiles in urinary extracellular vesicles associated with disease progression" was the awarded work.

Related professionals

Hugo Fernando Avalos  Bogado

Hugo Fernando Avalos Bogado

Predoctoral researcher
Rheumatology
Read more
Elba Agusti Rovira

Elba Agusti Rovira

Research technician
Donation and transplantation of organs, tissues and cells
Read more
Lucía Gutiérrez Ruiz

Lucía Gutiérrez Ruiz

Research technician
Clinical Neuroimmunology
Read more
Jon Esandi Jauregui

Jon Esandi Jauregui

Predoctoral researcher
Gene Therapy at Nervous System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.